Published in Naunyn Schmiedebergs Arch Pharmacol on November 01, 1997
Hyperalgesia, low-anxiety, and impairment of avoidance learning in neonatal caffeine-treated rats. Psychopharmacology (Berl) (2006) 0.91
Post-dural puncture headaches in children. A literature review. Eur J Pediatr (2003) 0.88
Combined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics? BMC Neurol (2011) 0.85
Analgesic and antineuropathic drugs acting through central cholinergic mechanisms. Recent Pat CNS Drug Discov (2011) 0.85
A Preliminary Study on the Effects of Self-Reported Dietary Caffeine on Pain Experience and Postoperative Analgesia. J Caffeine Res (2012) 0.77
The central analgesia induced by antimigraine drugs is independent from Gi proteins: superiority of a fixed combination of indomethacin, prochlorperazine and caffeine, compared to sumatriptan, in an in vivo model. J Headache Pain (2009) 0.75
Local anaesthetic activity of beta-caryophyllene. Farmaco (2001) 1.28
Effect of psychoactive drugs on the output of acetylcholine from the cerebral cortex of the cat. Eur J Pharmacol (1968) 1.15
Investigations into the acetylcholine output from the cerebral cortex of the cat in the presence of hyoscine. Br J Pharmacol Chemother (1967) 1.15
Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat. Proc Natl Acad Sci U S A (1997) 1.09
'Suicide' of crickets harbouring hairworms: a proteomics investigation. Insect Mol Biol (2006) 1.01
An antisense oligonucleotide on the mouse Shaker-like potassium channel Kv1.1 gene prevents antinociception induced by morphine and baclofen. J Pharmacol Exp Ther (1997) 0.96
Investigation into atropine-induced antinociception. Br J Pharmacol (1990) 0.94
Local anaesthetic activity of the essential oil of Lavandula angustifolia. Planta Med (1999) 0.93
Role of histamine in rodent antinociception. Br J Pharmacol (1994) 0.92
The hydrogen method of measuring local blood flow in subcortical structures of the brain: including a comparative study with the 14C antipyrine method. Exp Brain Res (1969) 0.92
Cerebral abscesses and necrotic cerebral tumours: differential diagnosis by perfusion-weighted magnetic resonance imaging. Radiol Med (2008) 0.91
The effect of oxotremorine on the acetylcholine content of different parts of cat brain. J Pharm Pharmacol (1970) 0.90
Effects of physostigmine on brain acetylcholine content and release. Neuropharmacology (1973) 0.90
Effect of K+ channel modulation on mouse feeding behaviour. Eur J Pharmacol (1997) 0.90
Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels. Br J Pharmacol (2001) 0.89
Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like K+ channel. Eur J Pharmacol (1997) 0.89
Local anaesthetic activity of (+)- and (-)-menthol. Planta Med (2001) 0.89
Central cholinergic challenging of migraine by testing second-generation anticholinesterase drugs. Headache (2002) 0.88
Effect of potassium channel modulators in mouse forced swimming test. Br J Pharmacol (1999) 0.88
Antinociception induced by amitriptyline and imipramine is mediated by alpha2A-adrenoceptors. Jpn J Pharmacol (2000) 0.88
Improvement of porphyrin cellular delivery and activity by conjugation to a carrier peptide. Bioconjug Chem (2001) 0.87
M1 receptor activation is a requirement for arecoline analgesia. Farmaco (2001) 0.87
Influence of potassium channel modulators on cognitive processes in mice. Br J Pharmacol (1998) 0.86
Role of 5-HT4 receptors in the mouse passive avoidance test. J Pharmacol Exp Ther (1998) 0.85
Protective effect of acetyl-L-carnitine on the apoptotic pathway of peripheral neuropathy. Eur J Neurosci (2007) 0.84
5-HT1A agonists induce central cholinergic antinociception. Pharmacol Biochem Behav (1997) 0.84
CGP 35348, a new GABAB antagonist, prevents antinociception and muscle-relaxant effect induced by baclofen. Br J Pharmacol (1991) 0.84
Pharmacological identification of SM-21, the novel sigma(2) antagonist. Pharmacol Biochem Behav (2000) 0.84
The central cholinergic system has a role in the antinociception induced in rodents and guinea pigs by the antimigraine drug sumatriptan. J Pharmacol Exp Ther (1996) 0.84
Loss of muscarinic antinociception by antisense inhibition of M(1) receptors. Br J Pharmacol (2000) 0.83
Involvement of potassium channels in amitriptyline and clomipramine analgesia. Neuropharmacology (2001) 0.83
Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice. Eur J Pharmacol (2001) 0.83
Tiagabine antinociception in rodents depends on GABA(B) receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis. Eur J Pharmacol (1999) 0.83
Antidepressant-like effects of endogenous histamine and of two histamine H1 receptor agonists in the mouse forced swim test. Br J Pharmacol (1998) 0.82
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. Pain (2009) 0.82
Memory facilitation and stimulation of endogenous nerve growth factor synthesis by the acetylcholine releaser PG-9. Jpn J Pharmacol (1998) 0.82
Effect of ICV taurine on the impairment of learning, convulsions and death caused by hypoxia. Psychopharmacology (Berl) (1989) 0.82
Effects of two histamine-N-methyltransferase inhibitors, SKF 91488 and BW 301 U, in rodent antinociception. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.81
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. Neuroscience (2003) 0.81
The neuropathy-protective agent acetyl-L-carnitine activates protein kinase C-gamma and MAPKs in a rat model of neuropathic pain. Neuroscience (2009) 0.81
Acetyl-L-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy. Neuroscience (2010) 0.81
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity. J Med Chem (2000) 0.81
Hybridized and isosteric analogues of N1-acetyl-N4-dimethyl-piperazinium iodide (ADMP) and N1-phenyl-N4-dimethyl-piperazinium iodide (DMPP) with central nicotinic action. Bioorg Med Chem (1999) 0.80
Epidemiology of burns at the Italian Red Cross Hospital in Baghdad. Burns (2005) 0.80
Antisense 'knockdowns' of M1 receptors induces transient anterograde amnesia in mice. Neuropharmacology (1999) 0.80
Desensitization of GABAB receptors and antagonism by CGP 35348, prevent bicuculline- and picrotoxin-induced antinociception. Neuropharmacology (1992) 0.80
Alpha-2 agonists induce amnesia through activation of the Gi-protein signalling pathway. Neuroscience (2004) 0.80
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8. Life Sci (1996) 0.80
Synthesis and biological activity of a series of aryl tropanyl esters and amides chemically related to 1H-indole-3-carboxylic acid endo 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester. Development of a 5-HT4 agonist endowed with potent antinociceptive activity. Arzneimittelforschung (1993) 0.80
Transverse dipoles added to DNA chains by drug binding can induce inversion of the long-range chirality of DNA condensates. Int J Biol Macromol (1993) 0.79
Regional arm-brain mean transit time in the diagnostic evaluation of patients with cerebral vascular disease. Stroke (1981) 0.79
Pharmacological in vivo test to evaluate the bioavailability of some St John's Wort innovative oral preparations. Phytother Res (2009) 0.79
Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse. Int J Clin Pharmacol Res (1997) 0.79
Kv1.1 channel antisense attenuates learning and modulation of dentate polysialylated NCAM. Neuroreport (1998) 0.79
Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception. Eur J Pharmacol (1996) 0.79
Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors. Br J Pharmacol (1999) 0.79
Role of 5-HT1A receptors in a mouse passive avoidance paradigm. Jpn J Pharmacol (2000) 0.79
Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers. CNS Drug Rev (2006) 0.79
Antinociceptive and antiamnesic properties of the presynaptic cholinergic amplifier PG-9. J Pharmacol Exp Ther (1998) 0.78
In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates. J Pharm Pharmacol (1985) 0.78
Local anaesthetic activity of monoterpenes and phenylpropanes of essential oils. Planta Med (2001) 0.78
Direct evidence that eseroline possesses morphine-like effects. Eur J Pharmacol (1982) 0.78
Reversible inhibition of acetylcholinesterase by eseroline, an opioid agonist structurally related to physostigmine (eserine) and morphine. Biochem Pharmacol (1982) 0.78
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. Neuropharmacology (2008) 0.78
Evidence for hypernociception induction following histamine H1 receptor activation in rodents. Life Sci (1998) 0.78
A reduced functionality of Gi proteins as a possible cause of fibromyalgia. J Rheumatol (2001) 0.78
Regional cerebral mode transit time and the derivative of the regional cerebral function recorded for intravenous administration of a non-diffusible tracer. Invest Radiol (1979) 0.78
The role of potassium channels in antihistamine analgesia. Neuropharmacology (1999) 0.78
Effect of photic stimulation on acetylcholine release from cat cerebral cortex. Neuropharmacology (1972) 0.78
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. J Med Chem (1998) 0.78
Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist. Brain Res Mol Brain Res (2003) 0.77
[Role of 5-hydroxytryptamine and of the acetylocholine in the anticonvulsive action of homotaurine]. Boll Soc Ital Biol Sper (1975) 0.77
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer. Naunyn Schmiedebergs Arch Pharmacol (2002) 0.77
Antiamnesic effect of metoprine and of selective histamine H(1) receptor agonists in a modified mouse passive avoidance test. Neurosci Lett (2000) 0.77
S-(-)-ET 126: a potent and selective M1 antagonist in vitro and in vivo. Life Sci (1996) 0.77
Eseroline: a new antinociceptive agent derived from physostigmine with opiate receptor agonist properties. Experimental in vivo and in vitro studies on cats and rodents. Neurosci Lett (1981) 0.77
Hypofunctionality of Gi proteins as aetiopathogenic mechanism for migraine and cluster headache. Cephalalgia (2001) 0.77